Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sumaira Yousuf, Shabnam Shabir & Mahendra P. Singh. (2023) Protection Against Drug-Induced Liver Injuries Through Nutraceuticals via Amelioration of Nrf-2 Signaling. Journal of the American Nutrition Association 42:5, pages 495-515.
Read now
Read now
Aviv Pudipeddi, Viraj Kariyawasam, Craig Haifer, Brandon Baraty, Sudarshan Paramsothy & Rupert WL Leong. (2019) Safety of drugs used for the treatment of Crohn’s disease. Expert Opinion on Drug Safety 18:5, pages 357-367.
Read now
Read now
Victoria Grossi & Jeffrey S. Hyams. (2016) The safety of treatment options for pediatric Crohn’s disease. Expert Opinion on Drug Safety 15:10, pages 1383-1390.
Read now
Read now
Ole Haagen Nielsen, Mehmet Coskun, Casper Steenholdt & Gerhard Rogler. (2015) The role and advances of immunomodulator therapy for inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 9:2, pages 177-189.
Read now
Read now
Gordon Liss & James H Lewis. (2009) Drug-induced liver injury: what was new in 2008?. Expert Opinion on Drug Metabolism & Toxicology 5:8, pages 843-860.
Read now
Read now
Articles from other publishers (23)
Orsolya Balázs, Ágnes Dombi, Balázs Zoltán Zsidó, Csaba Hetényi, Róbert György Vida & Miklós Poór. (2023) Probing the Interactions of 31 Mycotoxins with Xanthine Oxidase: Alternariol, Alternariol-3-Sulfate, and α-Zearalenol Are Allosteric Inhibitors of the Enzyme. Toxins 15:4, pages 250.
Crossref
Crossref
Violetta Mohos, Eszter Fliszár-Nyúl & Miklós Poór. (2020) Inhibition of Xanthine Oxidase-Catalyzed Xanthine and 6-Mercaptopurine Oxidation by Flavonoid Aglycones and Some of Their Conjugates. International Journal of Molecular Sciences 21:9, pages 3256.
Crossref
Crossref
Violetta Mohos, Attila Pánovics, Eszter Fliszár-Nyúl, Gabriella Schilli, Csaba Hetényi, Přemysl Mladěnka, Paul W. Needs, Paul A. Kroon, Gábor Pethő & Miklós Poór. (2019) Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme. International Journal of Molecular Sciences 20:11, pages 2681.
Crossref
Crossref
Christian P Selinger, Alvin Odouri Ochieng, Varun George & Rupert W Leong. (2019) The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios. Inflammatory Bowel Diseases 25:5, pages 919-924.
Crossref
Crossref
Kwang Il SeoSang-Bum Kang. (2019) Hepatobiliary Manifestation of Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 73:5, pages 248.
Crossref
Crossref
Sheng Zhang Lim & Eng Wee Chua. (2018) Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring. Frontiers in Pharmacology 9.
Crossref
Crossref
Sophie Restellini, Olivier Chazouillères & Jean‐Louis Frossard. (2016) Hepatic manifestations of inflammatory bowel diseases. Liver International 37:4, pages 475-489.
Crossref
Crossref
Mehmet Coskun, Casper Steenholdt, Nanne K. de Boer & Ole Haagen Nielsen. (2015) Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease. Clinical Pharmacokinetics 55:3, pages 257-274.
Crossref
Crossref
Misbah Misdaq, Sonia Ziegler, Nicolas von Ahsen, Michael Oellerich & Abdul R. Asif. (2015) Thiopurines Induce Oxidative Stress in T-Lymphocytes: A Proteomic Approach. Mediators of Inflammation 2015, pages 1-14.
Crossref
Crossref
U. Kopylov, D. Amre, Y. Theoret, C. Deslandres & E.G. Seidman. (2014) Thiopurine Metabolite Ratios for Monitoring Therapy in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 59:4, pages 511-515.
Crossref
Crossref
Viraj C. Kariyawasam, Christian P. Selinger, Peter H. Katelaris, D. Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Colliwshaw, Paul C. Lunney, Kate Middleton, Rosy R. Wang, Tony Huang, Jane Andrews & Rupert W. Leong. (2014) Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohnʼs Disease. Inflammatory Bowel Diseases 20:8, pages 1382-1390.
Crossref
Crossref
Maxime Doré, Anne Julie Frenette, Anne-Marie Mansour, Yves Troyanov & Josiane Bégin. (2014) Febuxostat as a Novel Option to Optimize Thiopurines’ Metabolism in Patients With Inadequate Metabolite Levels. Annals of Pharmacotherapy 48:5, pages 648-651.
Crossref
Crossref
Ivanka Curkovic, Katharina M. Rentsch, Pascal Frei, Michael Fried, Gerhard Rogler, Gerd A. Kullak-Ublick & Alexander Jetter. (2013) Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations. European Journal of Clinical Pharmacology 69:8, pages 1521-1531.
Crossref
Crossref
Yunki Yau, Rupert W Leong, Ming Zeng & Valerie C Wasinger. (2013) Proteomics and metabolomics in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 28:7, pages 1076-1086.
Crossref
Crossref
N. A. Kennedy, T. L. Asser, R. E. Mountifield, M. P. Doogue, J. M. Andrews & P. A. Bampton. (2013) Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Internal Medicine Journal 43:3, pages 278-286.
Crossref
Crossref
Maren E. S. Cotes & Robert A. Swerlick. (2013) Practical guidelines for the use of steroid-sparing agents in the treatment of chronic pruritus. Dermatologic Therapy 26:2, pages 120-134.
Crossref
Crossref
L. Chouchana, C. Narjoz, P. Beaune, M.‐A. Loriot & X. Roblin. (2011) Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 35:1, pages 15-36.
Crossref
Crossref
Xavier Roblin, Abderrahim Oussalah, Jean-Baptiste Chevaux, Miles Sparrow & Laurent Peyrin-Biroulet. (2011) Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: A worldwide survey of experts. Inflammatory Bowel Diseases 17:12, pages 2480-2487.
Crossref
Crossref
Melissa L. Haines, Yousef Ajlouni, Peter M. Irving, Miles P. Sparrow, Rosemary Rose, Richard B. Gearry & Peter R. Gibson. (2011) Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflammatory Bowel Diseases 17:6, pages 1301-1307.
Crossref
Crossref
Terreia S. Jones & Mary V. Relling. 2011. Pharmacogenomic Testing in Current Clinical Practice. Pharmacogenomic Testing in Current Clinical Practice
91
114
.
David Dunkin, Nanda Kerkar, Ronen Arnon, Frederick Suchy & Tamir Miloh. (2010) Allopurinol Salvage Therapy in Pediatric Overlap Autoimmune Hepatitis-Primary Sclerosing Cholangitis With 6-MMP Toxicity. Journal of Pediatric Gastroenterology & Nutrition 51:4, pages 524-526.
Crossref
Crossref
Richard B Gearry, Andrew S Day, Murray L Barclay, Rupert WL Leong & Miles P Sparrow. (2010) Azathioprine and allopurinol: A two-edged interaction. Journal of Gastroenterology and Hepatology 25:4, pages 653-655.
Crossref
Crossref
Choon Jin Ooi, Kwong Ming Fock, Govind K Makharia, Khean Lee Goh, Khoon Lin Ling, Ida Hilmi, Wee Chian Lim, Thia Kelvin, Peter R Gibson, Richard B Gearry, Qin Ouyang, Jose Sollano, Sathaporn Manatsathit, Rungsun Rerknimitr, Shu-chen Wei, Wai Keung Leung, H Janaka De Silva & Rupert WL Leong. (2010) The Asia-Pacific consensus on ulcerative colitis. Journal of Gastroenterology and Hepatology 25:3, pages 453-468.
Crossref
Crossref